Due to the fetoneonatal pathway it is possible to identify pregnant women with an increased risk of fetal growth restriction or pre-eclampsia in early stages (from 10th week of pregnancy). Women whose pregnancy is considered high-risk receives risk-adapted prenatal treatment as well as certain treatments for their newborn and infant until 1 year of age. The tasks of all involved persons are defined by standard operating procedures (SOP)
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Evaluation of patients' safety: maternal pre-eclampsia rate
Timeframe: through study completion, an average of 1 year and 7 months
Evaluation of patients' safety: newborn's birthweight adjusted by gestational age
Timeframe: through study completion, an average of 1 year and 7 months
Evaluation of patients' safety: maternal morbidity
Timeframe: through study completion, an average of 1 year and 7 months
Evaluation of patients' safety: infantil morbidity
Timeframe: through study completion, an average of 1 year and 7 months
Evaluation of patients' safety: Quality of life
Timeframe: through study completion, an average of 1 year and 7 months
Evaluation of patients' safety: attachment behavior
Timeframe: through study completion, an average of 1 year and 7 months
Evaluation of patient's access to treatment and satisfaction
Timeframe: through study completion, an average of 1 year and 7 months
claim of the health services
Timeframe: From admission to discharge, study inclusion to one year postpartum)
prohibition of employment
Timeframe: From admission to discharge, study inclusion to one year postpartum)
duration of unemployability
Timeframe: From admission to discharge, study inclusion to one year postpartum)